Latest News Title

Latest News

  • Media Release: Researchers discover why patients develop resistance to commonly-used cancer drug

    Michael Parker and Craig Morton, St Vincent’s Institute of Medical Research (SVI) in Melbourne Australia, and Bio21 Institute are part of an international team of collaborators that has made a discovery that may lead to more effective treatment and less side effects for a number of cancers including neuroblastoma, a cancer that occurs most commonly in infants and children under 5 years of age.

  • Lightning strikes twice for potential Parkinson’s disease and MND drug

    A phase 1 human clinical trial of a compound developed by Paul Donnelly, School of Chemistry and Kevin Barnham (Florey Institute of Neuroscience and Mental Health) whilst at the Bio21 Molecular Science and Biotechnology Institute and Anthony White, University of Melbourne and is showing promise in alleviating the symptoms of Parkinson’s disease.

  • Professor Emeritus Frances Separovic receives Queen's birthday honour

    Bio21's Professor Emeritus Frances Separovic, Deputy Director of the Bio21 Institute has been honoured with the appointment as an Officer (AO) of the Order of Australia (General Division) announced in the Queen's Birthday 2019 Honours List on 10 June 2019.

    Frances has been awarded an AO for her distinguished service to science education, particularly to biophysical chemistry, as an academic, and to young women scientists.

Latest News Link

Homepage Events Title


Homepage Events Link

Featured Projects Title


Featured Projects Link